Back to Research Hub
TransMedics Group, Inc.
TMDX
$71.11-0.12 (-0.16%)
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure.
StreetsValue research for TransMedics Group, Inc. (TMDX)
Members get the full report for TransMedics Group, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.